179 related articles for article (PubMed ID: 18613924)
21. Prognostic value of Ki-67 (MIB-1) and p53 in ependymomas.
Suzuki S; Oka H; Kawano N; Tanaka S; Utsuki S; Fujii K
Brain Tumor Pathol; 2001; 18(2):151-4. PubMed ID: 11908872
[TBL] [Abstract][Full Text] [Related]
22. Observer reliability in assessment of mitotic activity and MIB-1-determined proliferation rate in pediatric sarcomas.
Molenaar WM; Plaat BE; Berends ER; te Meerman GJ
Ann Diagn Pathol; 2000 Aug; 4(4):228-35. PubMed ID: 10982300
[TBL] [Abstract][Full Text] [Related]
23. Interobserver reproducibility of MIB-1 labeling index in astrocytic tumors using different counting methods.
Hsu CY; Ho DM; Yang CF; Chiang H
Mod Pathol; 2003 Sep; 16(9):951-7. PubMed ID: 13679460
[TBL] [Abstract][Full Text] [Related]
24. Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma.
Faratian D; Munro A; Twelves C; Bartlett JM
Histopathology; 2009 Jan; 54(2):254-7. PubMed ID: 19207951
[TBL] [Abstract][Full Text] [Related]
25. [Intracranial ependymomas in adult patients. Prognostic factors, place of surgery and complementary treatment].
Guyotat J; Metellus P
Neurochirurgie; 2007 Jun; 53(2-3 Pt 1):85-94. PubMed ID: 17418281
[TBL] [Abstract][Full Text] [Related]
26. DNA ploidy and nuclear morphometry in adult intracranial ependymomas.
Onguru O; Ulutin C; Celasun B; Gunhan O
Clin Neuropathol; 2003; 22(6):266-72. PubMed ID: 14672504
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
Suthipintawong C; Wejaranayang C; Vipupinyo C
J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
[TBL] [Abstract][Full Text] [Related]
28. Ki67 and p53 immunohistochemistry reduces interobserver variation in assessment of Barrett's oesophagus.
Lörinc E; Jakobsson B; Landberg G; Veress B
Histopathology; 2005 Jun; 46(6):642-8. PubMed ID: 15910595
[TBL] [Abstract][Full Text] [Related]
29. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer.
Gudlaugsson E; Skaland I; Janssen EA; Smaaland R; Shao Z; Malpica A; Voorhorst F; Baak JP
Histopathology; 2012 Dec; 61(6):1134-44. PubMed ID: 22963617
[TBL] [Abstract][Full Text] [Related]
31. Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer.
Margulis V; Lotan Y; Karakiewicz PI; Fradet Y; Ashfaq R; Capitanio U; Montorsi F; Bastian PJ; Nielsen ME; Müller SC; Rigaud J; Heukamp LC; Netto G; Lerner SP; Sagalowsky AI; Shariat SF
J Natl Cancer Inst; 2009 Jan; 101(2):114-9. PubMed ID: 19141773
[TBL] [Abstract][Full Text] [Related]
32. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
[TBL] [Abstract][Full Text] [Related]
33. The prognostic role of Ki-67 in childhood low-grade glioma.
Maurizi P; Ruggiero A; Attinà G; Cefalo MG; Arlotta A; Riccardi R
Pediatr Med Chir; 2008; 30(2):73-8. PubMed ID: 18581959
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of clinico-pathological criteria and the Ki67 index as prognostic indicators in canine insulinoma.
Buishand FO; Kik M; Kirpensteijn J
Vet J; 2010 Jul; 185(1):62-7. PubMed ID: 20570189
[TBL] [Abstract][Full Text] [Related]
35. Infratentorial ependymomas: prognostic factors and outcome analysis in a multi-center retrospective series of 106 adult patients.
Guyotat J; Metellus P; Giorgi R; Barrie M; Jouvet A; Fevre-Montange M; Chinot O; Durand A; Figarella-Branger D
Acta Neurochir (Wien); 2009 Aug; 151(8):947-60. PubMed ID: 19499166
[TBL] [Abstract][Full Text] [Related]
36. An intra- and interobserver reproducibility analysis of the Ki-67 proliferation marker assessment on core biopsies of breast cancer patients and its potential clinical implications.
Vörös A; Csörgő E; Nyári T; Cserni G
Pathobiology; 2013; 80(3):111-8. PubMed ID: 23258384
[TBL] [Abstract][Full Text] [Related]
37. [Prognostic and survival factors among pediatric patients with ependymomas].
López-Aguilar E; Sepúlveda-Vildósola AC; Betanzos-Cabrera Y; Gascón-Lastiri G; Ortiz-Suárez L; Rivera-Márquez H; Cerecedo-Díaz F; Wanzke-Del Angel V; De la Cruz-Yáñez H; Ramírez-Reyes G; Arenas-Aranda D; Siordia-Reyes G
Gac Med Mex; 2009; 145(1):7-13. PubMed ID: 19256405
[TBL] [Abstract][Full Text] [Related]
38. Ependymomas: MIB-1 proliferation index and survival.
Ritter AM; Hess KR; McLendon RE; Langford LA
J Neurooncol; 1998 Oct; 40(1):51-7. PubMed ID: 9874186
[TBL] [Abstract][Full Text] [Related]
39. Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients.
Song Z; Wang JL; Pan YL; Tao DY; Gan MF; Huang KE
Hepatogastroenterology; 2009; 56(89):149-53. PubMed ID: 19453047
[TBL] [Abstract][Full Text] [Related]
40. Intracranial ependymomas in children: society of pediatric oncology experience with postoperative hyperfractionated local radiotherapy.
Conter C; Carrie C; Bernier V; Geoffray A; Pagnier A; Gentet JC; Lellouch-Tubiana A; Chabaud S; Frappaz D
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1536-42. PubMed ID: 19362789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
